SCHEMBL2346242

SCHEMBL2346242

Cc1cccc(-n2c(N3CCNCC3)cc3ccccc32)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 5/20 0.60
▸ KHK P50053 1/20 0.43
▸ HTR3A P46098 6/20 0.42
▸ HTR1A P08908 6/20 0.42
▸ HTR3E A5X5Y0 3/20 0.42
▸ HTR3B O95264 3/20 0.42
▸ HTR3D Q70Z44 3/20 0.42
▸ HTR3C Q8WXA8 3/20 0.42
▸ SIGMAR1 Q99720 3/20 0.42
▸ HTR5A P47898 1/20 0.42
▸ HTR7 P34969 5/20 0.42
▸ HTR2A P28223 2/20 0.40
▸ HTR2C P28335 2/20 0.40
▸ KDR P35968 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555106 0.86 HTR3E (0.53) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2348220 0.85 ADRB1 (0.62) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2345155 0.84 HTR1A (0.44) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2343964 0.79 HTR7 (0.49) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2345082 0.78 HTR3E (0.48) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2346369 0.78 ADRB1 (0.53) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2342043 0.78 HTR3A (0.56) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL2348309 0.78 HTR3A (0.44) ADRB1HTR3AHTR1AHTR3EHTR3B
SCHEMBL81365 0.76 ADRB1 (1.00) ADRB1KHKHTR3AHTR1AHTR3E
SCHEMBL29391951 0.76 ADRB1 (1.00) ADRB1KHKHTR3AHTR1AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback